Ground breaking results from key trial : DAPA CKD

The much awaited outcome of the DAPA-CKD (Dapagliflozin And Prevention of Adverse Outcomes in Chronic Kidney Disease ) trial was presented on 30 August 2020 at the ESC (European Society of Cardiology) Congress 2020 by Prof H. Heerspink. Dapagliflozin is an SGLT2 ( Sodium-Glucose Co-transporter 2) inhibitor being used,so far, in the treatment of type… Continue reading Ground breaking results from key trial : DAPA CKD

The Filter, The Pump and The Pill

This is an abstract followed by the slides in pdf and video formats of the presentation made by Dr O Bheekharry for The Kidney Club on 16 July 2020. Diabetes mellitus (DM) affects around 25% of the Mauritian population and has important microvascular and macrovascular complications. Approximately 40% of DM type 2 patients have chronic… Continue reading The Filter, The Pump and The Pill